Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWP ...
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Canna ...
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Canna ...
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms
A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Cannabidiol (GWP42003-P) in infants with Infantile Spasms following an initial open label pilot study. A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Canna ...
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...